BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2283658)

  • 1. Clinical pharmacology of perindopril.
    Lees KR
    J Hum Hypertens; 1990 Oct; 4 Suppl 4():7-8; discussion 9-11. PubMed ID: 2283658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experience with perindopril in normal volunteers.
    Waeber B; Nussberger J; Perret L; Santoni JP; Brunner HR
    Clin Exp Hypertens A; 1989; 11 Suppl 2():507-19. PubMed ID: 2605800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experience with perindopril in normal volunteers.
    Waeber B; Nussberger J; Perret L; Santoni JP; Brunner HR
    Arch Mal Coeur Vaiss; 1989 May; 82 Spec No 1():35-41. PubMed ID: 2549899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical review of perindopril in the treatment of hypertension.
    Lerebours G; Antony I
    Can J Cardiol; 1994 Nov; 10 Suppl D():3D-7D. PubMed ID: 7954037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perindopril. A review of its pharmacokinetics and clinical pharmacology.
    Macfadyen RJ; Lees KR; Reid JL
    Drugs; 1990; 39 Suppl 1():49-63. PubMed ID: 2407493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of perindopril: therapeutic consequences.
    Lees KR; Hughes DM; McNeill CA; Reid JL
    Clin Exp Hypertens A; 1989; 11 Suppl 2():499-506. PubMed ID: 2605799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antihypertensive effect of perindopril. Experimental pharmacology].
    Barthelmebs M; Devissaguet M; Imbs JL
    Arch Mal Coeur Vaiss; 1989 May; 82 Spec No 1():17-24. PubMed ID: 2505709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihypertensive effect of perindopril: experimental pharmacology.
    Barthelmebs M; Devissaguet M; Imbs JL
    Clin Exp Hypertens A; 1989; 11 Suppl 2():471-86. PubMed ID: 2691126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of the dose-effect relationship of perindopril in the treatment of arterial hypertension].
    Luccioni R; Frances Y; Gass R; Gilgenkrantz JM
    Arch Mal Coeur Vaiss; 1989 May; 82 Spec No 1():43-50. PubMed ID: 2505712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemodynamic and humoral interactions between perindopril and indomethacin in essential hypertensive subjects.
    Abdel-Haq B; Magagna A; Favilla S; Salvetti A
    J Cardiovasc Pharmacol; 1991; 18 Suppl 7():S33-6. PubMed ID: 1725198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of perindopril treatment on plasma and urine of kallikrein activity and the stable metabolite of prostaglandin E2 in patients with essential hypertension.
    Zacharieva S; Torbova S; Orbetzova M; Borissova AM; Andonova K; Sheitanova S
    Methods Find Exp Clin Pharmacol; 1996 Apr; 18(3):205-9. PubMed ID: 8738072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the dose-effect relationship of perindopril in the treatment of hypertension.
    Luccioni R; Frances Y; Gass R; Gilgenkrantz JM
    Clin Exp Hypertens A; 1989; 11 Suppl 2():521-34. PubMed ID: 2605801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of perindopril on vascular smooth muscle polyploidy in stroke-prone spontaneously hypertensive rats.
    Devlin AM; Gordon JF; Davidson AO; Clark JS; Hamilton CA; Morton JJ; Campbell AM; Reid JL; Dominiczak AF
    J Hypertens; 1995 Feb; 13(2):211-8. PubMed ID: 7615951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perindopril plus nifedipine versus perindopril plus hydrochlorothiazide in mild to severe hypertension: a double-blind multicentre study. The Multicentre Study Group on Treatment Association with Perindopril.
    Letellier P; Overlack A; Agnes E; Desche P
    J Hum Hypertens; 1994 Feb; 8(2):145-9. PubMed ID: 8207741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of perindopril and hydrochlorothiazide alone and in combination on blood pressure and on the renin-angiotensin system in hypertensive subjects.
    Brown CL; Backhouse CI; Grippat JC; Santoni JP
    Eur J Clin Pharmacol; 1990; 39(4):327-32. PubMed ID: 2076713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of the suppressed kidney renin level in the hypertensive transgenic rat TGR(mRen-2)27 by angiotensin converting enzyme inhibition.
    Tokita Y; Franco-Saenz R; Mulrow PJ
    Am J Hypertens; 1995 Oct; 8(10 Pt 1):1031-9. PubMed ID: 8845072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent effects on blood pressure and renal function of perindopril alone or combined with losartan in Lyon hypertensive rats.
    Naelten G; Liu KL; Chapuis B; Lo M
    Am J Hypertens; 2005 May; 18(5 Pt 1):699-706. PubMed ID: 15882554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of perindopril on angiotensin converting enzyme in tissues of the rat.
    Jackson B; Cubela RB; Johnston CI
    J Hypertens Suppl; 1988 Dec; 6(3):S51-4. PubMed ID: 2852236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-lasting ex vivo inhibition by perindopril of rat vascular response to angiotensin I.
    Ishigai Y; Fukuzawa A; Chiba K; Irie K; Shibano T
    Methods Find Exp Clin Pharmacol; 1994 Nov; 16(9):633-8. PubMed ID: 7746024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimizing dose selection with modeling and simulation: application to the vasopeptidase inhibitor M100240.
    Pfister M; Martin NE; Haskell LP; Barrett JS
    J Clin Pharmacol; 2004 Jun; 44(6):621-31. PubMed ID: 15145970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.